Improving the efficiency of the development of drugs for strokeDavid W. Howells, Emily S. Sena, Victoria O'Collins, Malcolm R. MacleodThe mortality and morbidity associated with stroke makes the development of new drugs a research priority.

Blood biomarkers in stroke: research and clinical practice

Aug 6th, 2012 7m

Blood biomarkers may be useful in diagnosis, prediction or treatment for stroke, unfortunately discovery of these elusive blood biomarkers has so far been uneventful. However, there is hope according to the review Blood biomarkers in stroke: r

Neuroprotection for ischaemic stroke: translation from the bench to the bedside

Aug 6th, 2012 7m

The concept of neuroprotection has shown promise in experimental studies, but has failed to translate into clinical success.By preventing salvageable neurons from dying, neuroprotection seeks to restrict injury to the brain following an ischae

The use of animals as models: ethical considerations

Aug 6th, 2012 7m

The use of animals in scientific research is highly controversial. In the recent article for the Translational Research edition by Neil Levy, neuro-ethicist and ARC Future Fellow based at the Florey Neuroscience and Mental Health Institutes he

Stem cells in stroke treatment: the promise and the challenges

Jul 16th, 2012 14m 13s

The article ‘Stem cells in stroke treatment: the promise and the challenges’ published in the IJS translational research edition looks at challenges facing the development of stem cell therapy for stroke. Carmen Lahiff-Jenkins Managing Editor o

Rate